Completed PHASE2 INTERVENTIONAL 3-arm NCT04994821

TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study

A Phase 2 Study to Investigate Use of Transcranial Direct Current Stimulation (tDCS) to Reduce Craving in Cocaine Addiction

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions Cocaine Dependence Cocaine Use Disorder

Interventions Cognitive Reappraisal transcranial direct current stimulator (tDCS)

Updated 5 times since 2021 Last updated: Nov 14, 2024 Started: Sep 28, 2020 Primary completion: Mar 31, 2022 Completion: Sep 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cocaine Dependence and Cocaine Use Disorder, this trial is completed. The trial is conducted by Icahn School of Medicine at Mount Sinai and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Dec 2024 — Present [monthly]

Completed PHASE2

Status: Unknown → Completed
Sep 2024 — Dec 2024 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Sep 2023 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Sep 2021 — Sep 2023 [monthly]

Recruiting PHASE2

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai
Soterix Medical

Data source: Soterix Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States